Business Context and Reporting Period
This Form 8-K is a current report filed by Unicycive Therapeutics, Inc. (UNCY) on May 21, 2025. The filing addresses a logistical update regarding the company's 2025 Annual Meeting of Stockholders. The company is incorporated in Delaware and trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an "Other Events" filing and does not contain financial statements or performance data.
Material Changes
The only material change disclosed is the time of the 2025 Annual Meeting of Stockholders:
- Previous Time: Not specified in this excerpt, but the time has been changed.
- New Time: 7:00 a.m. Pacific Daylight Time.
- Date and Location: Unchanged. The meeting remains scheduled for June 9, 2025, at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
- Record Date: April 30, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly serves to notify stockholders of the meeting time adjustment.
Investor Verification Checklist
- Verify the new meeting time of 7:00 a.m. PDT on June 9, 2025, to ensure attendance.
- Confirm stockholder status as of the April 30, 2025 record date.
- Review the press release (Exhibit 99.1) for any additional context not included in the summary.
- Check the company website or proxy materials for voting instructions and participation details.